摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(Methylamino)-1-(naphthalen-1-yl)ethan-1-ol | 1242161-63-2

中文名称
——
中文别名
——
英文名称
2-(Methylamino)-1-(naphthalen-1-yl)ethan-1-ol
英文别名
2-(methylamino)-1-naphthalen-1-ylethanol
2-(Methylamino)-1-(naphthalen-1-yl)ethan-1-ol化学式
CAS
1242161-63-2
化学式
C13H15NO
mdl
——
分子量
201.268
InChiKey
CPSMZZCHIVFDQF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    32.3
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    2-(Methylamino)-1-(naphthalen-1-yl)ethan-1-ol溶剂黄146 、 sodium nitrite 作用下, 以 为溶剂, 生成 N-(2-hydroxy-2-naphthalen-1-ylethyl)-N-methylnitrous amide
    参考文献:
    名称:
    Synthesis, in Vitro Activity, and Three-Dimensional Quantitative Structure−Activity Relationship of Novel Hydrazine Inhibitors of Human Vascular Adhesion Protein-1
    摘要:
    Vascular adhesion protein-1 (VAP-1) belongs to the semicarbazide-sensitive amine oxidases (SSAOs) that convert amines into aldehydes. SSAOs are distinct from the mammalian monoamine oxidases (MAOs), but their substrate specificities are partly overlapping. VAP-1 has been proposed as a target for anti-inflammatory drug therapy because of its role in leukocyte adhesion to endothelium. Here, we describe the synthesis and in vitro activities of novel series of VAP-1 selective inhibitors. In addition, the molecular dynamics simulations performed for VAP-1 reveal that the movements of Met211, Ser496, and especially Leu469 can enlarge the ligand-binding pocket, allowing larger ligands than those seen in the crystal structures to bind. Combining the data from molecular dynamics simulations, docking, and in vitro measurements, the three-dimensional quantitative structure-activity relationship (3D QSAR) models for VAP-1 (q(LOO)(2): 0.636; r(2:) 0.828) and MAOs (q(LOO)(2): 0.749, r(2): 0.840) were built and employed in the development of selective VAP-1 inhibitors.
    DOI:
    10.1021/jm100337z
点击查看最新优质反应信息